Post-earnings recap
Reported
Mon, May 4, 2026
EPS actual
$-0.71
EPS est.
$-0.54
EPS surprise
-31.48%
1-day move
-6.97%
Twist Bioscience's earnings report showed a larger-than-expected loss per share, which contributed to a 6.97% decline in stock price. The lack of revenue figures and guidance may raise concerns among investors about the company's future performance. Overall, the disappointing EPS result indicates potential challenges ahead for the company.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.71 | $-0.53 | -31.48% |
| Revenue | N/A | $108M | N/A |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.
Twist Bioscience Corporation is a biotechnology company that specializes in DNA synthesis and gene editing technologies. Operating in the health care sector, Twist aims to enable advancements in fields like synthetic biology, pharmaceuticals, and diagnostics, making it a key player in the evolving biotech landscape.
Last quarter
In Q1-2026, Twist reported an EPS of $-0.50, which was a slight miss compared to the estimate of $-0.47. Following the earnings report, the stock saw a positive reaction, gaining nearly 14% the next day.
EPS beat streak
0Q
EPS beat rate
38%
Avg EPS surprise
+14.51%
Avg 1-day reaction
+0.19%
Analysts expect Twist to report a loss of $-0.53 per share on revenues of $108 million for Q2-2026. The market is closely watching these figures to assess the company's growth trajectory.
Bull case
If Twist can exceed the revenue expectations and show signs of improving margins, it could signal a turnaround in its financial performance, leading to a positive stock reaction.
Bear case
Conversely, if the company fails to meet revenue expectations or reports a wider loss, it could raise concerns about its growth strategy and lead to a negative market reaction.
Key metrics to watch
Earnings Per Share (EPS)
$-0.53EPS is a crucial indicator of the company's profitability and financial health, helping investors gauge performance against expectations.
Revenue
$108MRevenue reflects the company's ability to generate sales and is essential for assessing growth and market demand for its products.
The print will turn on these.
Q1
Will Twist's revenue meet or exceed the consensus estimate of $108 million?
Revenue performance is critical for assessing the company's growth and market demand, which will heavily influence investor sentiment.
Q2
What specific strategies is management implementing to improve EPS, currently estimated at $-0.53?
Understanding management's approach to improving profitability is essential for evaluating the company's future potential and operational efficiency.
—
Est. EPS
$3.37
Est. Rev
$709M
Impl. Move
±3.2%
Why consensus could be wrong
The Street may be underestimating Twist's potential for revenue growth due to its innovative product offerings and expanding market presence.
Supporting evidence
Despite recent misses, Twist's technology pipeline suggests potential for significant revenue increases not reflected in current estimates.
The options market is pricing in a larger move than historical averages, indicating that traders expect a more substantial shift in stock price than the consensus suggests.
Key risk
If Twist's revenue growth exceeds $108 million, it could challenge the current bearish sentiment and shift investor expectations.
Pre-commit to what would confirm each case.
This quarter, the debate centers around whether Twist can demonstrate solid revenue growth and a path to profitability amid ongoing market challenges.
Bull confirmed if
Revenue growth exceeding $108 million with a reduction in EPS loss to below $-0.50 would confirm the bull case.
Bear confirmed if
A revenue miss below $107 million or an EPS loss greater than $-0.53 would confirm the bear case.
What the market is pricing for the move.
Implied Move
±15.73%
Historical Avg
±9.2%
The options market is pricing in a significant move of about 15.73%, indicating that investors expect volatility around the earnings announcement.
Options are pricing ±15.7% while TWST has averaged ±9.2% over the last 8 prints — setup is pricing rich.
ATM IV
1.1%
30d HV
75.0%
Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.
Bought
$0.00
0 sh
0 insiders
Sold
$21.0M
110,997 sh
6 insiders
Net
$21.0M
Net selling
Most Active Insiders· 25 open-market trades
$10.6M
Net selling
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Twist beats expectations, history suggests a positive stock reaction, averaging a 0.72% increase the following day, confirming a bullish outlook.
In line / cautious
If results are in line with expectations but management's commentary is cautious, the stock may see muted movement as investors reassess growth prospects.
Miss
A miss on earnings could lead to a decline, with historical patterns indicating an average drop of around 5.90% following such outcomes.
The lines on the call that would change the story.
$4.9M
Net selling
$1.9M
Net selling
$1.8M
Net selling
Recent Transactions
Oct 2, 2026 · @ $188.88
45,736 sh
$8.6M
Oct 2, 2026 · @ $188.88
25,714 sh
$4.9M
Oct 2, 2026 · @ $188.88
10,088 sh
$1.9M
Oct 2, 2026 · @ $188.88
9,514 sh
$1.8M
Oct 2, 2026 · @ $188.88
8,057 sh
$1.5M
Open-market trades only (Form 4 codes P/S). Awards, exercises, and tax-withholding excluded as routine compensation noise.